Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    12829672 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases
Condition: Metastatic Brain Cancer
Interventions: Radiation: Whole Brain IMRT;   Radiation: Conventional Whole Brain RT
2 Terminated Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases
Conditions: Neoplasm Metastasis;   Brain Neoplasms
Intervention: Drug: Motexafin gadolinium

Indicates status has not been verified in more than two years